Operating, investing and financing flows differ from the reported change in cash by 19000000, beyond tolerance 18220000.00.
CISCO SYSTEMS, INC. (CSCO) reported revenue of $17.25B and net income of $3.86B for the fiscal year ended 2026-07-25. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from CISCO SYSTEMS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Computer Communications Equipment.
Income
| Metric | 2026-07-25 | 2026-04-25 | 2026-01-24 | 2025-10-25 | 2025-07-26 | 2025-04-26 | 2025-01-25 | 2024-10-26 | 2024-07-27 | 2024-04-27 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.25B | $15.84B | $15.35B | $14.88B | $14.67B | $14.15B | $13.99B | $13.84B | $13.64B | $12.70B |
| Cost of revenue | $6.19B | $5.76B | $5.38B | $5.14B | $5.39B | $4.87B | $4.88B | $4.72B | $4.86B | $4.43B |
| Gross profit | $11.06B | $10.08B | $9.97B | $9.74B | $9.28B | $9.28B | $9.11B | $9.12B | $8.78B | $8.27B |
| Operating income | $4.26B | $3.96B | $3.78B | $3.36B | $3.09B | $3.20B | $3.11B | $2.36B | $2.62B | $2.19B |
| Net income | $3.86B | $3.37B | $3.18B | $2.86B | $2.55B | $2.49B | $2.43B | $2.71B | $2.16B | $1.89B |
| Research & development | $2.43B | $2.38B | $2.36B | $2.40B | $2.38B | $2.34B | $2.30B | $2.29B | $2.18B | $1.95B |
| Weighted-average diluted shares | Unavailable | shares 3.98B | shares 3.98B | shares 3.99B | Unavailable | shares 4.00B | shares 4.00B | shares 4.01B | Unavailable | shares 4.06B |
| Pretax income | $4.93B | $4.04B | $3.65B | $3.39B | $3.00B | $2.95B | $2.89B | $2.27B | $2.40B | $2.24B |
| Income tax expense | $1.07B | $666.00M | $471.00M | $531.00M | $449.00M | $456.00M | $459.00M | -$444.00M | $234.00M | $349.00M |
| Diluted EPS | Unavailable | $0.85 | $0.80 | $0.72 | Unavailable | $0.62 | $0.61 | $0.68 | Unavailable | $0.46 |
| Selling, general & administrative | $3.63B | $3.52B | $3.57B | $3.60B | $3.52B | $3.46B | $3.42B | $3.55B | $3.60B | $3.30B |
| General & administrative | $679.00M | $661.00M | $688.00M | $733.00M | $706.00M | $739.00M | $752.00M | $795.00M | $763.00M | $736.00M |
| Selling & marketing | $2.95B | $2.86B | $2.88B | $2.87B | $2.82B | $2.72B | $2.67B | $2.75B | $2.84B | $2.56B |
Balance
| Metric | 2026-07-25 | 2026-04-25 | 2026-01-24 | 2025-10-25 | 2025-07-26 | 2025-04-26 | 2025-01-25 | 2024-10-26 | 2024-07-27 | 2024-04-27 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7.22B | $7.08B | $7.46B | $8.40B | $8.35B | $8.16B | $8.56B | $9.06B | $7.51B | $8.91B |
| Total assets | $129.64B | $125.55B | $123.37B | $121.10B | $122.29B | $119.78B | $121.38B | $123.33B | $124.41B | $123.00B |
| Current assets | $38.66B | $36.56B | $35.13B | $32.88B | $34.99B | $32.82B | $34.68B | $35.75B | $36.86B | $35.89B |
| Total liabilities | $79.35B | $76.68B | $75.65B | $74.23B | $75.45B | $73.85B | $75.84B | $78.06B | $78.96B | $77.23B |
| Current liabilities | $41.52B | $39.54B | $36.79B | $35.45B | $35.06B | $34.50B | $40.02B | $40.54B | $40.58B | $40.11B |
| Total equity incl. NCI | $50.28B | $48.86B | $47.72B | $46.87B | $46.84B | $45.94B | $45.53B | $45.28B | $45.46B | $45.77B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $5.69B | $4.71B | $3.92B | $3.40B | $3.16B | $2.83B | $2.93B | $3.14B | $3.37B | $3.12B |
| Accounts receivable | $7.47B | $6.48B | $6.61B | $4.83B | $6.70B | $5.28B | $5.67B | $4.46B | $6.68B | $5.13B |
| Goodwill | $59.48B | $59.29B | $59.23B | $59.12B | $59.14B | $59.02B | $58.72B | $58.77B | $58.66B | $58.63B |
| Long-term debt | $19.37B | $19.37B | $21.37B | $21.36B | $22.86B | $22.86B | $19.62B | $19.62B | $19.62B | $20.10B |
| Accounts payable | $3.37B | $2.97B | $2.76B | $2.42B | $2.53B | $2.26B | $1.90B | $2.00B | $2.30B | $2.05B |
Cash flow
| Metric | 2026-07-25 | 2026-04-25 | 2026-01-24 | 2025-10-25 | 2025-07-26 | 2025-04-26 | 2025-01-25 | 2024-10-26 | 2024-07-27 | 2024-04-27 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.39B | $3.76B | $1.82B | $3.21B | $4.23B | $4.06B | $2.24B | $3.66B | $3.73B | $3.97B |
| Capital expenditures | $390.00M | $414.00M | $283.00M | $323.00M | $217.00M | $261.00M | $210.00M | $217.00M | $198.00M | $168.00M |
| Investing cash flow | -$264.00M | -$2.07B | -$1.31B | $156.00M | -$273.00M | $505.00M | $1.02B | $479.00M | -$828.00M | -$22.82B |
| Financing cash flow | -$5.01B | -$2.04B | -$1.44B | -$3.86B | -$3.95B | -$5.14B | -$3.94B | -$2.78B | -$4.51B | $14.07B |
| Net change in cash | $144.00M | -$376.00M | -$942.00M | -$509.00M | -$8.00M | -$590.00M | -$700.00M | $1.37B | -$1.60B | -$4.78B |
| Stock-based compensation | $927.00M | $914.00M | $934.00M | $1.06B | $948.00M | $945.00M | $921.00M | $827.00M | $800.00M | $811.00M |
| Common dividends paid | $1.66B | $1.66B | $1.62B | $1.62B | $1.62B | $1.63B | $1.59B | $1.59B | $1.61B | $1.62B |
| Common share repurchases | $1.50B | $1.25B | $1.36B | $1.99B | $1.25B | $1.50B | $1.24B | $2.00B | $2.02B | $1.27B |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2026-07-25 | 2026-04-25 | 2026-01-24 | 2025-10-25 | 2025-07-26 | 2025-04-26 | 2025-01-25 | 2024-10-26 | 2024-07-27 | 2024-04-27 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $5.00B | $3.34B | $1.54B | $2.89B | $4.02B | $3.80B | $2.03B | $3.44B | $3.53B | $3.80B |
| Gross margin | 64.1% | 63.6% | 65.0% | 65.5% | 63.2% | 65.6% | 65.1% | 65.9% | 64.4% | 65.1% |
| Operating margin | 24.7% | 25.0% | 24.6% | 22.6% | 21.0% | 22.6% | 22.3% | 17.0% | 19.2% | 17.2% |
| FCF margin | 29.0% | 21.1% | 10.0% | 19.4% | 27.4% | 26.8% | 14.5% | 24.9% | 25.9% | 29.9% |
| SBC / revenue | 5.4% | 5.8% | 6.1% | 7.1% | 6.5% | 6.7% | 6.6% | 6.0% | 5.9% | 6.4% |
| Current ratio | 0.93x | 0.92x | 0.96x | 0.93x | 1.00x | 0.95x | 0.87x | 0.88x | 0.91x | 0.89x |
| Revenue YoY growth | 17.6% | 12.0% | 9.7% | 7.5% | 7.6% | 11.4% | 9.4% | -5.6% | -10.3% | -12.8% |
| Net margin | 22.4% | 21.3% | 20.7% | 19.2% | 17.4% | 17.6% | 17.4% | 19.6% | 15.8% | 14.8% |
| R&D / revenue | 14.1% | 15.0% | 15.3% | 16.1% | 16.2% | 16.5% | 16.4% | 16.5% | 16.0% | 15.3% |
| CapEx / revenue | 2.3% | 2.6% | 1.8% | 2.2% | 1.5% | 1.8% | 1.5% | 1.6% | 1.5% | 1.3% |
| Long-term debt / equity | 0.39x | 0.40x | Unavailable | Unavailable | 0.49x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 21.8% | 16.5% | 12.9% | 15.7% | 15.0% | 15.5% | 15.9% | -19.6% | 9.8% | 15.6% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CSCO in the interactive workspace to inspect any figure back to its filing.
Source filings
Reconciliation checks needing review
5 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
Operating, investing and financing flows differ from the reported change in cash by 45000000, beyond tolerance 38000000.00.
Operating, investing and financing flows differ from the reported change in cash by 93000000, beyond tolerance 52190000.00.
Operating, investing and financing flows differ from the reported change in cash by 98000000, beyond tolerance 47390000.00.
Operating, investing and financing flows differ from the reported change in cash by 95000000, beyond tolerance 39620000.00.